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EDITORIAL
Mitigating costs for people living with TB: from measurement 
to action
D. J. Carter,1 D. Pedrazzoli2
It is well understood that TB is a consequence of pov-erty: we must similarly understand that TB may also 
be a cause of poverty. The recent paper by Sinha et al. 
adds important evidence on the financial burden of 
TB, particularly on the high indirect costs faced by 
people living with TB in India, who face mean indirect 
costs of US$667.00.1
Lost income associated with loss of employment or 
time lost while seeking or staying in care accounted 
for the largest single share of total costs in a number 
of countries that conducted nationally representative 
patient cost surveys.2 In India, the majority of these 
costs were incurred pre-diagnosis or during the inten-
sive phase of treatment. Indirect costs incurred 
through job loss and lost wages especially can fuel cy-
cles of poverty, and the measurement of such costs 
demonstrates how TB leads to impoverishment.
As the authors suggest in their article, the Indian 
direct benefit transfer (DBT) for people living with TB 
provides a strong opportunity to break the cycle of 
poverty through the provision of in-kind or cash sup-
port, alongside other existing social protection strate-
gies. However, people living with TB are regularly not 
covered by suitable social protection systems or these 
programmes do not meet their specific needs.3,4 A re-
cent mixed-methods study demonstrated that there 
are still substantial delays and barriers to accessing 
DBT, affecting the ability of patients to defray their 
costs.5 As the majority of costs in the Indian context 
are pre-diagnosis, facilitating better access to social 
protection for those most vulnerable to TB might de-
fray costs even before interaction with the health 
system.
As indirect costs due to job loss are such a large 
component of total costs, providing more compre-
hensive social protection floors is warranted. Public 
health action could be taken through promoting or 
legislating policies that can support job retention for 
people living with TB, such as paid sick leave or flexi-
ble working arrangements. Other possibilities for inte-
grating social action with biomedical approaches may 
entail having screening or preventive treatment avail-
able in the workplace, alongside the creation of links 
with trade unions and other organisations that pro-
tect workers. Such policies also provide the opportu-
nity to reduce stigma. While the TB community is 
slowly moving towards action on direct costs, policies 
that address indirect costs have so far been over-
looked, as they require true multisectoral action and 
dialogue.6
Studies such as Sinha et al.’s are invaluable for 
quantifying costs. As the evidence base on the pres-
ence of catastrophic costs becomes increasingly 
strong, the international TB community must start ef-
fectively using this wealth of knowledge to inform 
policies and practices that can alleviate the financial 
burden of the disease. This study provides yet another 
call for the TB community to think beyond biomedi-
cal approaches for mitigating catastrophic costs and 
other consequences of TB. Social protection alone may 
not be a silver bullet, but it remains an underutilised 
tool in the arsenal for the fight against TB.
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